Nuclear targeting of stanniocalcin to mammary gland alveolar cells during pregnancy and lactation

In most mammalian tissues, the stanniocalcin-1 gene (STC-1) produces a 50-kDa polypeptide hormone known as STC50. Within the ovaries, however, the STC-1 gene generates three higher-molecular-mass variants known as big STC. Big STC is targeted locally to corpus luteal cells to block progesterone rele...

Full description

Saved in:
Bibliographic Details
Published inAmerican journal of physiology: endocrinology and metabolism Vol. 52; no. 4; pp. E634 - E642
Main Authors HASILO, Craig P, MCCUDDEN, Christopher R, GILLESPIE, J. Ryan J, JAMES, Kathi A, HIRVI, Edward R, ZAIDI, Deenaz, WAGNER, Graham F
Format Journal Article
LanguageEnglish
Published Bethesda, MD American Physiological Society 01.10.2005
Subjects
Biological and medical sciences
Breastfeeding & lactation
Cells
Fundamental and applied biological sciences. Psychology
Genes
Hormones
Pregnancy
Vertebrates: endocrinology
Pregnancy
Mitochondria
membrane
receptor
Targeting
Lactation
nucleus
Mammary gland
Biological receptor
Online AccessGet full text

Cover

More Information
Summary:In most mammalian tissues, the stanniocalcin-1 gene (STC-1) produces a 50-kDa polypeptide hormone known as STC50. Within the ovaries, however, the STC-1 gene generates three higher-molecular-mass variants known as big STC. Big STC is targeted locally to corpus luteal cells to block progesterone release. During pregnancy and lactation, however, ovarian big STC production increases markedly, and the hormone is released into the serum. During lactation, this increase in hormone production is dependent on a suckling stimulus, suggesting that ovarian big STC may have regulatory effects on the lactating mammary gland. In this report, we have addressed this possibility. Our results revealed that virgin mammary tissue contained large numbers of membrane- and mitochondrial-associated STC receptors. However, as pregnancy progressed into lactation, there was a decline in receptor densities on both organelles and a corresponding rise in nuclear receptor density, most of which were on milk-producing, alveolar cells. This was accompanied by nuclear sequestration of the ligand. Sequestered STC resolved as one 135-kDa band in the native state and therefore had the appearance of a big STC variant. However, chemical reduction collapsed this one band into six closely spaced, lower-molecular-mass species (28-41 kDa). Mammary gland STC production also underwent a dramatic shift during pregnancy and lactation. High levels of STC gene expression were observed in mammary tissue from virgin and pregnant rats. However, gene expression then fell to nearly undetectable levels during lactation, coinciding with the rise in nuclear targeting. These findings have thus shown that the mammary glands are indeed targeted by STC, even in the virgin state. They have further shown that there are marked changes in this targeting pathway during pregnancy and lactation, accompanied by a switch in ligand source (endogenous to exogenous). They also represent the first example of nuclear targeting by STC. [PUBLICATION ABSTRACT]
ISSN:0193-1849
1522-1555